Singapore markets closed

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.67+1.02 (+6.96%)
At close: 04:00PM EST
15.88 +0.21 (+1.34%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close14.65
Bid15.75 x 800
Ask15.90 x 900
Day's range14.15 - 15.77
52-week range9.72 - 33.97
Avg. volume4,117,819
Market cap2.032B
Beta (5Y monthly)0.69
PE ratio (TTM)N/A
EPS (TTM)-1.22
Earnings date22 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est31.56
  • Motley Fool

    My 3 Top Biopharma Stock Picks for 2022

    Thanks to the dual headwinds of sky-high inflation and the threat of rising interest rates, biopharmaceutical stocks appear poised for a turbulent 2022. Underscoring this point, investors have been dumping risky clinical and early commercial-stage biopharma stocks over the past several weeks in response to these closely intertwined macro variables. This year thus seems destined to be a bona fide "stock-picker's market" for biopharma investors.

  • Business Wire

    Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences

    VICTORIA, British Columbia, January 04, 2022--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the "Company") today announced that members of the management team will participate in two upcoming virtual investor conferences.

  • Zacks

    Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

    Investors need to pay close attention to CorMedix (AUPH) stock based on the movements in the options market lately.